- Title
- Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms
- Creators - without role
- Jean-Yves L. Reginster - University of LiègeOlivier Bruyere - University of LiègeCyrus Cooper - MRC Lifecourse Epidemiology Unit
- Publication Details
- Annals of the rheumatic diseases, Vol.77(7), pp.e39-e39
- Publisher
- Bmj Publishing Group
- Number of pages
- 2
- Grant note
- Zodiac PharmEvo IBSA-Genevrier TRB Chemedica Nutraveris Radius Health Medtronic Meda IBSA Nycomed-Takeda MSD Eli Lilly Genevrier Servier Pfizer AMGEN; Amgen Novartis Rottapharm Will Pharma GSK; GlaxoSmithKline Bayer; Bayer AG SMB MC_U147585819; G0400491; MC_U147585827 / MRC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) UCB; UCB Pharma SA Alliance for Better Bone Health Asahi-Kasei; Asahi Kasei Corporation Roche; Roche Holding
- Identifiers
- 9949175508331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article
Journal article
Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms
Annals of the rheumatic diseases, Vol.77(7), pp.e39-e39
01/07/2018
PMID: 28877867
Metrics
1 Record Views